kinetabio.com - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur KA

Tandha merek Kineta, Inc. (KA)

The development of immune activation agents is constrained by patents and the immense financial risks associated with early-stage testing. The 12-month revenue trajectory illustrates current dynamics, where the actual level equals 0.00. Kineta, Inc. (KA) seeks to confirm the efficacy of its anti-tumor drugs, yet the suspension of research to cut costs and uncertainty regarding management's actions cast doubt on the assets' ability to recover from the crisis.

Kineta Inc - Wutah dodolan YoY (TTM) KA (periode 11.02.2024 - 20.02.2024)

Ringkesan rincian data analitis Kineta (KA)

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:KA (Kineta Corp)
Produk asil prodhuksi kinetabio.com

To assess the asset quality of Kineta, Inc. (KA), it is critical to track revenue scaling rates amid the outsourcing of antibody production. By analyzing year-over-year sales dynamics over the last four quarters, an investor can observe the daily price action of turnover over twelve months, enabling the timely identification of capital freeze risks in inventories should the company's liquidity levels prove insufficient.

Pesaing Kineta, Inc. (KA)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|MAIA Biotechnology Inc (MAIA) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur liminatuspharma.com|Wutah dodolan YoY sajrone rolas wulan kepungkur LVTX|Wutah pendapatan YoY sajrone 12 wulan kepungkur NXTC (NextCure, Inc.)|LPTX: Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Wutah pendapatan taun lumaku|TOVX: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Gritstone bio - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur